untitled
|
|
- みひな しもとり
- 5 years ago
- Views:
Transcription
1
2 vs
3
4
5
6
7 12,
8 16
9
10
11
12
13
14
15 Poroma /
16 vs.
17
18
19
20
21
22
23
24
25 1. decapitation secretion apocrine snout apical snout pinching-off fringe scalloping
26
27
28
29 Cuticular cells Poroid cells Cuticular cells Poroid cells!
30 Poroid cell Cuticular cell poroid cell Poroma poroid cells
31
32
33
34
35 /
36
37
38
39
40
41 Eccrine poroma Syringocystadenoma papilliferum Syringoma Mixed tumor
42
43
44 Poroma
45
46
47 /
48
49 A. 1. Hidrocystoma (Cystadenoma) 2. Apocrine tubular adenoma 3. Hidradenoma 4. Clear cell hidradenoma 5. Hidradenoma papilliferum 6. Syringocystadenoma papilliferum 7. Mixed tumor B. 1. Apocrine carcinoma Mucinous carcinomas Cerminous adenoma/carcinoma 2. Extramammary Paget s s disease
50 C. 1. (Eccrine mixed tumor) 2. Syringoma 3. Spiradenoma 4. Cylindroma 5. Poroma Hidracanthoma simplex Eccrine poroma Dermal duct tumor Poroid hidradenoma clonal type 6. Eccrine spiradenoma D. 1. Porocarcinoma de novo developed in poroma 2. Malignant spiradenoma Eccrine spiradenocarcinoma 3. Eccrine carcinoma (syringomatous carcinoma) Microcystic adnexal tumor Digital papillary adenocarcinoma
51 1. Hidrocystoma (Cystadenoma) 2. Apocrine tubular adenoma 3. Syringoma 4. Poroma Hidracanthoma simplex Eccrine poroma Dermal duct tumor Poroid hidradenoma Clonal type 5. Porocarcinoma 6. Hidradenoma 7. Clear cell hidradenoma 8. Hidradenoma papilliferum 9. Syringocystadenoma papilliferum 10. Spiradenoma 11. Cylindroma 12. Mixed tumor 13. Apocrine carcinoma Mucinous carcinomas Cerminous adenoma/carcinoma 14. Extramammary Paget s s disease 15. Microcystic adnexal tumor
52 Hidrocystoma Cystadenoma
53 Apocrine hidrocystoma Apocrine cystadenoma ( ) Median raphe cysts
54 Apocrine hidrocystoma
55 Apocrine hidrocystoma
56 Apocrine hidrocystoma
57 Apocrine tubular adenoma
58 Apocrine tubular adenoma Papillary tubular adenoma DX DX HPV
59 Apocrine tubular adenoma
60 Apocrine tubular adenoma
61 Syringoma 2/3 2/3
62 Syringoma
63 Syringoma
64 Syringoma
65 Syringoma
66 Syringoma
67 Syringoma
68 Poroma Hidracanthoma simplex 2. Eccrine poroma poroma 3. Dermal duct tumor 4. Poroid hidradenoma
69 Poroma
70 Poroma
71 Poroma Hidracanthoma simplex A B Eccrine poroma C D Dermal duct tumor Poroid hidradenoma Abenoza P and Ackerman AB Neoplasm s with eccrine differentiation
72 Hidracanthoma simplex
73 Eccrine Poroma
74 Dermal duct tumor
75 Poroid hidradenoma
76 Poroma Hidradenoma simplex Eccrine poroma Dermal duct tumor Poroid hidradenoma
77 Poroma
78 Poroma
79 Poroma
80 Poroma, clonal type Poroma
81
82 Poroid cell poroid cell
83
84 + Poroid cell + cuticular cells
85 Porocarcinoma /de novo
86 Porocarcinoma
87 Porocarcinoma
88 Porocarcinoma
89 Porocarcinoma
90 Porocarcinoma de novo
91 Porocarcinoma (de novo)
92 Porocarcinoma
93 Porocarcinoma SCC
94 Hidro- : Hidradenoma Poroid hidradenoma Clear cell hidradenoma clear cell myoepithelioma, nodular hidradenoma, eccrine sweat gland adenoma of clear cell type, solid and cystic hidradenoma, eccrine acrospiroma Clear cell hidradenoma solid- (nodular-), cystic-, solid & cysticapocrine-, eccrine-
95 Poroid hidradenoma Poroma
96 Clear cell hidradenoma
97 Hidradenoma
98 Hidradenoma
99 Hidradenoma papilliferum
100 Hidradenoma papilliferum
101 Syringocystadenoma papilliferum
102 Syringocystadenoma papilliferum
103 Spiradenoma
104 Spiradenoma N/C
105 Spiradenoma
106 Spiradenoma
107
108 Spiradenoma
109 Spiradenocarcinoma 1) >> 2) de novo 1) 2) N/C N/C
110 Spiradenocarcinoma
111 spiradenocarcinoma
112 spiradenocarcinoma
113 Spiradenocarcinoma
114 Cylindroma N/C N/C
115 Cylindroma 66
116 Cylindroma
117 Cylindroma
118
119
120 Mixed tumor
121 Mixed tumor
122 Mixed tumor
123
124
125 Mixed tumor
126 Mixed tumor
127 Mixed tumor
128 Eccrine mixed tumor Mixed tumor
129
130
131 Apocrine carcinoma
132 Apocrine carcinoma ceruminous gland Moll gland GCDFP-15 (+)
133 Apocrine carcinoma
134 Apocrine carcinomas
135 Apocrine carcinoma GCDFP-15
136 Extramammary Paget s s disease
137 Extramammary Paget s disease
138 Extramammary Paget s disease
139 Extramammary Paget s disease
140 Extramammary Paget s disease
141 Extramammary Paget s disease
142 Extramammary Paget s disease
143 Extramammary Paget s carcinoma
144 Extramammary Paget s disease
145 Microcystic adnexal carcinoma Sclerosing sweat duct carcinoma, Syringomatous carcinoma
146 Microcystic adnexal carcinoma
147 Microcystic adnexal carcinoma
148 Microcystic adnexal carcinoma
149 MAC syringoid eccrine ca. eccrine epithelioma, basal cell epithelioma with eccrine differentiation, eccrine ca. with syringomatous feature, sweat gland ca. with syringomatous feature, malignant syringoma, eccrine basalioma Ackerman AB Syringomatous carcinoma - well - moderately - poorly
150 ABC ABC (*^_^*)
151
152
腫瘍・アポクリン・エクリンなら新しい皮膚科学|皮膚病全般に関する最新情報を載せた皮膚科必携テキスト
390 章皮膚の良性腫瘍 2. 脂腺腺腫 sebaceous adenoma 中高年の顔面, 頭皮に好発する黄色調の結節および腫瘤. 病 理組織学的に脂腺分化を示す良性腫瘍である. 3. 脂腺腫 ( 脂腺上皮腫 ) sebaceoma(sebaceous epithelioma) 図.11 脂腺腫 (sebaceoma) 顔面や頭皮に生じるドーム状あるいは有茎性の結節 ( 図.11). 黄色調を呈することもある.
More informationuntitled
27 10 4 1. : 4 4 2015 2016 2015 2020 2019 5 1 20 5 100 2021 2020 5 2021 5 5 3 2. : 3 6 7 HP https://center6.umin.ac.jp/oasis/pathology/senmonikenshu_150813.html 9 11 HP 27 12 18 28 4 9 18 Q&A 3. http://pathology.or.jp/senmoni/newsystem.html
More information参考文献 1. Hampe, J.F. and Misdorp, W. (1974) Tumours and dysplasias of the mammary gland. Bull WHO 50: Moulton, JE, (1990) Tumors of the Mamma
乳腺腫瘍の組織分類について マルピー ライフテック ( 以下 MLT) では 1993 年の病理検査業務開始時点から乳腺腫瘍の組織分類に関しては Dr. Narama の提唱された分類を使用してきましたが このたび 2017 年に発行された Tumors in Domestic Animals, 5 th ed に記載されている組織分類 (TDA5) を使用する事にいたしました 犬猫 ( 動物 )
More informationMicrosoft Word - 倫理 第40,43,45,46講 テキスト.docx
6 538 ( 552 ) (1) () (2) () ( )( ) 1 vs () (1) (2) () () () ) ()() (3) () ( () 2 () () () ()( ) () (7) (8) () 3 4 5 abc b c 6 a (a) b b ()() 7 c (c) ()() 8 9 10 () 1 ()()() 2 () 3 1 1052 1051 () 1053 11
More information00 0 0 0 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.... 0........ 0 0 0 0 0 0 0 0 0 0..0..........0 0 0 0 0 0 0 0 0 0 0.... 0........ 0 0 0 0 0 0 0 0 0 0... 0...... 0... 0 0 0 0 0 0..0 0... 0 0 0 0 0.0.....0.
More information; cm 4. ; 2. ; 3. ; 5. 2 ; 120 ng/ml Mφ 6 7, 8 9
32, 21-25, 2012 CASLE 1 1 80 26 6 5 4 cm 1 2 CEA 3 4 CEA 2 44 22 2 3 1.5 cm 22 1. 1 ; 6 5 4 cm 4. ; 2. ; 3. ; 5. 2 ; 120 ng/ml 0-40 5 Mφ 6 7, 8 9 23 6. ; 9. ; 7. ; 10. ; 8. 7 10 CK3 CK3 24 1,2 3 2 8% 4,5
More information合併後の交付税について
(1) (2) 1 0.9 0.7 0.5 0.3 0.1 2 3 (1) (a), 4 (b) (a), (c) (a) 0.9 0.7 0.5 0.3 0.1 (b) (d),(e) (f) (g) (h) (a) (i) (g) (h) (j) (i) 5 (2) 6 (3) (A) (B) (A)+(B) n 1,000 1,000 2,000 n+1 970 970 1,940 3.0%
More information膵癌超音波診(案)
1 2 3 4 5 6 7 8 9 10 2009 7 6 2 a. invasive ductal carcinoma * 1 b. endocrine neoplasm c. Solid pseudopapillary neoplasm d. tumor producing pancreatitis * 2 * 1 invasive ductal carcinomas papillary adenocarcinoma
More information取扱説明書 [F-02F]
F-02F 4. 2 3 4 5 6 7 8 9 0 2 3 4 5 6 7 8 a b c d a b c d a b cd 9 e a b c d e 20 2 22 ab a b 23 a b 24 c d e 25 26 o a b c p q r s t u v w d h i j k l e f g d m n a b c d e f g h i j k l m n x 27 o
More information5 isomorphic responseisotopic response 6 BP180 ELISA Darier solitary sclerotic fibroma 65 Spitz micr
5 isomorphic responseisotopic response 6 BP180 ELISA 14 21 Darier 25 29 33 2 37 41 45 49 53 57 61 solitary sclerotic fibroma 65 Spitz 69 73 77 81 microcystic adnexal carcinoma 85 89 19 95 98 21 110 114
More information2002.N.x.h.L.......g9/20
1 2 3 4 5 6 1 2 3 4 5 8 9 1 11 11 12 13 k 14 l 16 m 17 n 18 o 19 k 2 l 2 m 21 n 21 o 22 p 23 q 23 r 24 24 25 26 27 28 k 28 l 29 m 29 3 31 34 42 44 1, 8, 6, 4, 2, 1,2 1, 8 6 4 2 1, 8, 6, 4, 2, 1,2 1, 8
More informationS61 腎腫瘍 [ 岡山大学医歯薬学総合研究科病理学 ( 腫瘍 )] Renal cell carcinoma *Clear cell papillary renal cell carcinoma Clear cell tubulopapillary RCC (carcinoma) Clear ce
日本病理学会中国四国支部学術集会 ( 第 10 回スライドカンファレンス ) 診断投票結果 日時 : 平成 8 年 6 月 6 日 ( 日 ) 会場 : 香川大学医学部臨床講義棟 階 * Speaker s diagnosis S60 腎生検 [ 香川大学医学部附属病院病理診断科 ] Glomerular deposition disease Light chain deposition disease
More information超音波40-5廣岡先生(膵癌)_念*.indd
1 2 3, 4, 5, 6, 7, 8, 9, 10 11,.2009 7 6,, 2.,,.,.,,,.,,,.,,,,.,,.,. a. invasive ductal carcinoma * 1 b. neuroendocrine neoplasm c. Solid-pseudopapillary neoplasm d. mass-forming tumor-producing pancreatitis
More informationMicrosoft Word - stage.doc
2009 4 6 General Rules for the Study of Pancreatic Cancer April 2009 (The 6th Edition) Japan Pancreas Society - 1 - I 1 II 2 III 3 1 3 1 3 2 4 3 5 4 5 2 7 1 7 2 10 3 11 IV 12 1 12 2 12 1 12 2 12 3 12 3
More informationCA CA19-9 CA19-9 CA CA CA19-9 ARCHITECT i 2000SR CLIA U/mL CA % CA CA
原 著 30 22-29, 2015 CA19-9 CA19-9 CA19-9 2006 12013 6 CA19-9 32,508 37.0U/mL 790 2 CA19-9 320 CA19-9 ARCHITECT i 2000SRCLIA 0.0 37.0U/mL 8 4 1 2 18CA19-9 198.2 46.4 2,968 U/mL 5 3 2.5% CA19-9 2.5% CA19-9
More informationEPSON VP-1200 取扱説明書
4020178-01 w p s 2 p 3 4 5 6 7 8 p s s s p 9 p A B p C 10 D p E 11 F G H H 12 p G I s 13 p s A D p B 14 C D E 15 F s p G 16 A B p 17 18 s p s 19 p 20 21 22 A B 23 A B C 24 A B 25 26 p s p s 27 28 p s p
More informationFig. 1. Chest X-ray film on admission showed a mass in the left middle lung field and multiple nodular densities in the bilateral lung fields. Fig. 3.
A Case of Slow-growing Mucous-producing Adenocarcioma of the Lung Key words: Mucous-producing lung adenocarcinoma, Slow-growing, Bronchial gland cell type adenocarcinoma, Adenoid cystic carcinoma Table
More information26 2 3 4 5 8 9 6 7 2 3 4 5 2 6 7 3 8 9 3 0 4 2 4 3 4 4 5 6 5 7 6 2 2 A B C ABC 8 9 6 3 3 4 4 20 2 6 2 2 3 3 4 4 5 5 22 6 6 7 7 23 6 2 2 3 3 4 4 24 2 2 3 3 4 4 25 6 2 2 3 3 4 4 26 2 2 3 3 27 6 4 4 5 5
More informationmogiJugyo_slide_full.dvi
a 2 + b 2 = c 2 (a, b, c) a 2 a 2 = a a a 1/ 78 2/ 78 3/ 78 4/ 78 180 5/ 78 http://www.kaijo.ed.jp/ 6/ 78 a, b, c ABC C a b B c A C 90 a 2 + b 2 = c 2 7/ 78 C a b a 2 +b 2 = c 2 B c A a 2 a a 2 = a a 8/
More information1 2 3 4 5 6 X Y ABC A ABC B 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 13 18 30 P331 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 ( ) 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59
More informationJA2008
A1 1 10 vs 3 2 1 3 2 0 3 2 10 2 0 0 2 1 0 3 A2 3 11 vs 0 4 4 0 0 0 0 0 3 6 0 1 4 x 11 A3 5 4 vs 5 6 5 1 0 0 3 0 4 6 0 0 1 0 4 5 A4 7 11 vs 2 8 8 2 0 0 0 0 2 7 2 7 0 2 x 11 A5 9 5 vs 3 10 9 4 0 1 0 0 5
More information新たな基礎年金制度の構築に向けて
[ ] 1 1 4 60 1 ( 1 ) 1 1 1 4 1 1 1 1 1 4 1 2 1 1 1 ( ) 2 1 1 1 1 1 1 1996 1 3 4.3(2) 1997 1 65 1 1 2 1/3 ( )2/3 1 1/3 ( ) 1 1 2 3 2 4 6 2.1 1 2 1 ( ) 13 1 1 1 1 2 2 ( ) ( ) 1 ( ) 60 1 1 2.2 (1) (3) ( 9
More informationuntitled
No.16 TBS TBS TBS 1 2 2 Low High 2 3 TBS ASC-USASC-H TBS TBS TBS TBS ASCASC-US,ASC-H TBS ASC ASC LSIL ASC-US HSIL ASC-H ASC 1 ASC HPV HPV TBS HPV HPV ASC-US ASC-US ASC-H ASC-US ASC-US ASC-H ASC-H
More information1 2 3 4 5 1 1 136 2 137 2 1 1 138 2 1 2 139 140 141 142 3 143 3 144 145 4 1 2 146 3 4 147 5 1 2 3 148 1 2 149 3 5 1 2 150 3 151 1 152 2 153 6 1 2 154 3 155 4 1 156 2 3 4 5 157 7 1 2 3 4 158 5 159 6 8 1
More informationO157 6/23 7/4 6 25 1000 117,050 6 14:00~15:30 1 2 22 22 14:30~15:30 8 12 1 5 20 6 20 10 11 30 9 10 6 1 30 6 6 0 30 6 19 0 3 27 6 20 0 50 1 2 6 4 61 1 6 5 1 2 1 2 6 19 6 4 15 6 1 6 30 6 24 30 59
More informationEPSON エプソンプリンタ共通 取扱説明書 ネットワーク編
K L N K N N N N N N N N N N N N L A B C N N N A AB B C L D N N N N N L N N N A L B N N A B C N L N N N N L N A B C D N N A L N A L B C D N L N A L N B C N N D E F N K G H N A B C A L N N N N D D
More informationありがとうございました
- 1 - - 2 - - 3 - - 4 - - 5 - 1 2 AB C A B C - 6 - - 7 - - 8 - 10 1 3 1 10 400 8 9-9 - 2600 1 119 26.44 63 50 15 325.37 131.99 457.36-10 - 5 977 1688 1805 200 7 80-11 - - 12 - - 13 - - 14 - 2-1 - 15 -
More informationEPSON エプソンプリンタ共通 取扱説明書 ネットワーク編
K L N K N N N N N N N N N N N N L A B C N N N A AB B C L D N N N N N L N N N A L B N N A B C N L N N N N L N A B C D N N A L N A L B C D N L N A L N B C N N D E F N K G H N A B C A L N N N N D D
More information公務員人件費のシミュレーション分析
47 50 (a) (b) (c) (7) 11 10 2018 20 2028 16 17 18 19 20 21 22 20 90.1 9.9 20 87.2 12.8 2018 10 17 6.916.0 7.87.4 40.511.6 23 0.0% 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2.0% 4.0% 6.0% 8.0%
More informationQ1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 A B (A/B) 1 1,185 17,801 6.66% 2 943 26,598 3.55% 3 3,779 112,231 3.37% 4 8,174 246,350 3.32% 5 671 22,775 2.95% 6 2,606 89,705 2.91% 7 738 25,700 2.87% 8 1,134
More information橡hashik-f.PDF
1 1 1 11 12 13 2 2 21 22 3 3 3 4 4 8 22 10 23 10 11 11 24 12 12 13 25 14 15 16 18 19 20 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 144 142 140 140 29.7 70.0 0.7 22.1 16.4 13.6 9.3 5.0 2.9 0.0
More information198
197 198 199 200 201 202 A B C D E F G H I J K L 203 204 205 A B 206 A B C D E F 207 208 209 210 211 212 213 214 215 A B 216 217 218 219 220 221 222 223 224 225 226 227 228 229 A B C D 230 231 232 233 A
More informationネットショップ・オーナー2 ユーザーマニュアル
1 1-1 1-2 1-3 1-4 1 1-5 2 2-1 A C 2-2 A 2 C D E F G H I 2-3 2-4 2 C D E E A 3 3-1 A 3 A A 3 3 3 3-2 3-3 3-4 3 C 4 4-1 A A 4 B B C D C D E F G 4 H I J K L 4-2 4 C D E B D C A C B D 4 E F B E C 4-3 4
More information1
1 2 3 4 5 (2,433 ) 4,026 2710 243.3 2728 402.6 6 402.6 402.6 243.3 7 8 20.5 11.5 1.51 0.50.5 1.5 9 10 11 12 13 100 99 4 97 14 A AB A 12 14.615/100 1.096/1000 B B 1.096/1000 300 A1.5 B1.25 24 4,182,500
More information05[ ]戸田(責)村.indd
147 2 62 4 3.2.1.16 3.2.1.17 148 63 1 3.2.1.F 3.2.1.H 3.1.1.77 1.5.13 1 3.1.1.05 2 3 4 3.2.1.20 3.2.1.22 3.2.1.24 3.2.1.D 3.2.1.E 3.2.1.18 3.2.1.19 2 149 3.2.1.23 3.2.1.G 3.1.1.77 3.2.1.16 570 565 1 2
More information/9/ ) 1) 1 2 2) 4) ) ) 2x + y 42x + y + 1) 4) : 6 = x 5) : x 2) x ) x 2 8x + 10 = 0
1. 2018/9/ ) 1) 8 9) 2) 6 14) + 14 ) 1 4 8a 8b) 2 a + b) 4) 2 : 7 = x 8) : x ) x ) + 1 2 ) + 2 6) x + 1)x + ) 15 2. 2018/9/ ) 1) 1 2 2) 4) 2 + 6 5) ) 2x + y 42x + y + 1) 4) : 6 = x 5) : x 2) x 2 15 12
More informationQW-3414
MA1312-C P 1 2 3 A E L D E D A A E D A D D D D D E A C A C E D A A A C A C A C E E E D D D A C A C A A A A C A C A C E E C C E D D C C C E C E C C E C C C E D A C A C A C E L B B
More information2003 Giemsa HE HE AE1+AE3 HBME1 HE HE Well differentiated adenocarcinoma of colon Giemsa HE HE 62 Group V HE 47 Group V Peritoneal dissemination of gastric cancer HE 51 Poorly differentiated Adenocarcinoma(por2)
More information9 10 Addison Cronkhite-Canada 27 ADAR1 c.1798ct minocycline-induced cutaneous hyperpigmentation 47 PL 51 Laugier-Hunziker-Baran 5
9 10 Addison 15 19 23 Cronkhite-Canada 27 ADAR1 c.1798ct 31 35 39 43 minocycline-induced cutaneous hyperpigmentation 47 PL 51 Laugier-Hunziker-Baran 55 57 59 pencil-core granuloma 61 63 67 69 Let s enjoy
More information901 902 2 40 5 786 30 2 2 100 10100200 903 904 2 3 2 12 905 6765 30 3 61016 1 10162532 253240 2 2 1 2 100 24 45 545 1 2 2 510 1515 1010 50 300 0 10 2942 560 2 1 1 2 24 15 2565 2 10 2942 560 3 3 56 03 18
More information1037 1038 2 40 5 876 30 2 2 100 10100200 1039 1040 2 3 2 12 1041 6765 30 1 1 2 2 1 2 100 24 45 545 1 2 2 510 1515 1010 50 300 0 10 2942 560 2 1 3 2 10 2942 560 3 61016 1 10162532 253240 1 2 24 15 2565
More information宿泊産業活性化のための実証実験
121 32 10 12 12 19 2 15 59 40 33 34 35 36 37 38 3637 20 39 12 19 OFF 2008/12/19 2008/12/25 3 1 1 72,000 2008/12/19 2008/12/26 2 1 1 36,000 2008/12/28 2009/1/5 2 1 1 24,000 2009/1/6 2009/1/16 3 1 1 25,200
More informationしうる 3. 亜部位と局在コード ICD-O 局在取扱い規約表記 部位 C44.0 口唇口唇の皮膚, NOS 下唇の皮膚 上唇の皮膚 C44.1 眼瞼 C44.2 耳 C44.3 顔面 鼻 頬 C44.4 頭部 項頚部 C44.5 腋窩 胸部 上腹 ( 臍上 ) 下 腹 背部 ( 第 12 胸椎下縁
皮膚 Skin (C44.0-C44.9, C51.0-C51.9, C60.9, C63.2) 皮膚に原発する悪性腫瘍は ICD-O 分類の場合 局在コード C44.0-C44.9, C51.0-C51.9, C60.9, C63.2 に分類される UICC 第 7 版においては 眼瞼 外陰 陰茎以外の皮膚に原発した癌腫の場合 皮膚癌 の項で分類する 眼瞼に発生した癌腫は 眼瞼の皮膚癌 の項で 外陰
More information_06.indd
30, 35-39, 2010 0.15% 1 C 40 20 1 cm 5 mm WBC 9,400, RBC 259 10 4, Hb 8.5 g/dl, Ht 25.5%, Plt 29 10 4, BUN 116 mg/dl, Cr 7.9 mg/dl, 125 mg/dl, HbA1c 4.3%, ft3 1.97 pg/ml, ft4 1.05 ng/dl, TSH 1.09 μiu/ml,
More information日本消化器外科学会雑誌第23巻第2号
Key words: carcinoma of the pancreatic head, carcinoma of the periampullary region, operative results of the pancreatic duodenal carcinoma, mode of tumor spread of the pancreatic duodenal carcinoma, factors
More information> > <., vs. > x 2 x y = ax 2 + bx + c y = 0 2 ax 2 + bx + c = 0 y = 0 x ( x ) y = ax 2 + bx + c D = b 2 4ac (1) D > 0 x (2) D = 0 x (3
13 2 13.0 2 ( ) ( ) 2 13.1 ( ) ax 2 + bx + c > 0 ( a, b, c ) ( ) 275 > > 2 2 13.3 x 2 x y = ax 2 + bx + c y = 0 2 ax 2 + bx + c = 0 y = 0 x ( x ) y = ax 2 + bx + c D = b 2 4ac (1) D >
More informationnonepisodic angioedema associated with eosinophilianeae 27 chronic actinic dermatitis 31 drug-induced hypersensitivity syndromedihs 35 neutrop
9-11 20 nonepisodic angioedema associated with eosinophilianeae 27 chronic actinic dermatitis 31 drug-induced hypersensitivity syndromedihs 35 neutrophilic eccrine hidradenitissweet 39 43 paraneoplastic
More information6 J1 ---------------------------------------------------------------- LSI 6 6 12 1 : 2013 : : 2 : 2015 : : 3??? LSI 3 5 1 : 60 2,000 12 --------------
27 7 3 4 2015 2020 5 5 1 1 3 : ABS 3 6 7 : 27 27 8 1 2 27 28 2 13 14 : No Football No Life 1996 40 6 7 2010 100 100 J 1 6 J1 ---------------------------------------------------------------- LSI 6 6 12
More informationA Case of Ceruminous Adenoma Keisaku Tabuchi (Tenri Hospital) Etsuo Yamamoto (Kyoto University) Shinsuke Ito (Kurume University) Kazunori Mori (Toyook
A Case of Ceruminous Adenoma Keisaku Tabuchi (Tenri Hospital) Etsuo Yamamoto (Kyoto University) Shinsuke Ito (Kurume University) Kazunori Mori (Toyooka Hospital) Ceruminous adenoma is very rare, especially
More informationepidermal nevus syndrome 41 Becker nevus syndrome y 45 incontinentia pigmenti 49 hypomelanosis of Ito 53 LEOPARD unil
9 10 14 19 25 1 29 2 33 37 epidermal nevus syndrome 41 Becker nevus syndrome y 45 incontinentia pigmenti 49 hypomelanosis of Ito 53 LEOPARD 57 61 unilateral dermatomal cavernous hemangiomatosis 65 69 75
More informationSquamous papilloma
山 口 大 学 医 学 部 病 理 腫 瘍 総 論 第 6 回 第 5 回 のおさらい 浸 潤 と 転 移 - 悪 性 腫 瘍 の 最 大 の 特 徴 リンパ 行 性 転 移 血 行 性 転 移 播 種 病 期 (ステージについて) 病 期 (ステージ)とは TNM 分 類 のしくみ 良 性 腫 瘍 と 悪 性 腫 瘍 のちがい 肉 眼 的 相 違 点 と 組 織 学 的 相 違 点 本 日 の 講
More information,2) 3) 2) 4) 2) 5) 5) 6) 6) 1,2) class 19.5 MRI 21x15 calponin p SPA Key words: 1) 2) 3) 4) 5) 6) Masa
91 15 19 2015 1 1,2) 3) 2) 4) 2) 5) 5) 6) 6) 1,2) 2014 11 6 2014 12 1 18 2 class 19.5 MRI 21x15 calponin p63 2 3 SPA Key words: 1) 2) 3) 4) 5) 6) Masaki Suzuki 1,2), Hironori Noge 3), Michiyo Kambe 2),
More informationEPSON LP-8900ユーザーズガイド
3 4 5 6 7 8 abc ade w p s 9 10 s s 11 p 12 p 13 14 p s 15 p s A B 16 w 17 C p 18 D E F 19 p w G H 20 A B 21 C s p D 22 E s p w 23 w w s 24 p w s 25 w 26 p p 27 w p s 28 w p 29 w p s 30 p s 31 A s B 32
More informationPowerPoint プレゼンテーション
症例 1: Intraductal papilloma 乳頭状集塊の出現や 背景の泡沫状マクロファージの出現から 嚢胞内乳頭状病変が示唆される 細胞集塊は全体的に結合性が強く 乳頭状集塊の中心には比較的太い線維性結合織が認められ 集塊内とくに腺上皮と線維性結合織の間には筋上皮の介在が窺われる LBC 検体を用いた免疫染色では シート状集塊において高分子量サイトケラチン (CK5/6) のモザイク状陽性所見が認められ
More informationdrug-induced hypersensitivity syndrome 31 necrobiotic xanthogranuloma advisor
9 10 16 19 23 27 drug-induced hypersensitivity syndrome 31 necrobiotic xanthogranuloma 35 39 43 47 51 55 61 65 70 71 advisor 73 92 102 107 109 31 110 114 125 126 133 metastatic tuberculosis abscess 137
More informationPSCHG000.PS
a b c a ac bc ab bc a b c a c a b bc a b c a ac bc ab bc a b c a ac bc ab bc a b c a ac bc ab bc de df d d d d df d d d d d d d a a b c a b b a b c a b c b a a a a b a b a
More information500 DIY 500 20 500=10,000 ---------------------------------------------------------------- 13 4 11 13 10 2 30 20 20 ----------------------------------
27 4 2 : 4 2014 8 2014 11 2015 3 16 2015 A E 5 A B C E : 4 9 : B 4 1-3 ii a. 1 3 1 3 1 : A, B, S 2015 4 2017 4 2017 4 2016 HP : 27 27 8 1-2 27 28 2 13 : 1 1 1 3 1 20 30 1 500 DIY 500 20 500=10,000 ----------------------------------------------------------------
More informationpbl(renal) LI
シナリオの病理診断設定 renal cell carcinoma / granular cell carcinoma G2, pt2, INFa,v(+) 組織学的分類 (WHO ( 分類 1998 年 ) 年 )[1] 良性腺腫 Renal cell benign adenoma 乳頭状 / 管状乳頭状腺腫 Papillary/tubulopapillary adenoma オンコサイトーマ Oncocytoma
More information取扱説明書 [F-12D]
12.7 ISSUE DATE: NAME: PHONE NUMBER: MAIL ADDRESS: F-12D e e e 1 e 2 1 2 3 4 5 6 7 8 9 10 11 a b c d a b c d 12 a b cd e a b c d e 13 14 15 a b c d 16 17 a b d a b e f g h i l m e n o p c j k c q r s t
More information(1) (2) (3) (1) (2) (3) (1) (2) (3) (4) (1) (2)
(1) (2) (3) (1) (2) (3) (1) (2) (3) (4) (1) (2) (1) (2) (3) (1) (2) (3) (1) (2) (3) vs. (2) (1) 16 22 143,977 24,030 55,769 600 (2) (3) (4) (1) (2) (1) (2) 2 (3) (abuse) (1) (2) (3) (1) (2) (3)
More information1 (1) vs. (2) (2) (a)(c) (a) (b) (c) 31 2 (a) (b) (c) LENCHAR
() 601 1 () 265 OK 36.11.16 20 604 266 601 30.4.5 (1) 91621 3037 (2) 20-12.2 20-13 (3) ex. 2540-64 - LENCHAR 1 (1) vs. (2) (2) 605 50.2.13 41.4.27 10 10 40.3.17 (a)(c) 2 1 10 (a) (b) (c) 31 2 (a) (b) (c)
More information07637_2007 皮膚科の臨床 Vol.49
Vol. 49. No. 13. Clinicolor 1 3 AL 119 50 Phialophora verrucosa 1 231 1 423 533 655 Pinkus 763 877 997 Mucinous Carcinoma of the Skin 1 1317 1 1425 Queyrat 1 1537 She can be happy. 5 121 233 425 535 657
More informationTable 1. Numbers of Cancerous Pleurisy Cases According to Primary Site Table 2. Histological Type of Lung Carcinoma with Cancerous Pleurisy at Autopsy
Clinicopathological Studies on Cancerous Pleurisy, with Emphasis on Extra-Pulmonary Malignancy Table 1. Numbers of Cancerous Pleurisy Cases According to Primary Site Table 2. Histological Type of Lung
More information9 11 Xanthomonas maltophilia SweetSjögren eosinophilic cellulitis 45 cytophagic histiocytic panniculitis
9 11 Xanthomonas maltophilia 17 21 25 29 33 SweetSjögren 37 41 eosinophilic cellulitis 45 cytophagic histiocytic panniculitis 49 53 57 61 65 69 73 77 40 94 99 101 103 114 129 53 130 5 139 ADR 3 145 153
More informationThe vaginal smears obtained from a 63-year-old woman revealed malignant features such as hyperchromasia, coarse gnanular chromatin and enlarge- ment of N/C ratio. Tadpole and fiber shaped malignant cells
More informationÿþ
YV-18 YV-19 YV-20 HALS Surgrx Enseal System 5 29 16:10 17:10 1-1 YP-1 YP-2 YP-3 YP-4 YP-5 YP-6 1 20 TS1 2 5 29 16:10 17:10 1-2 YP-7 YP-8 YP-9 YP-10 YP-11 YP-12 1 IPMN 1 4 3 2 Gemcitabine 5 29 16:10 17:10
More information18 ( ) I II III A B C(100 ) 1, 2, 3, 5 I II A B (100 ) 1, 2, 3 I II A B (80 ) 6 8 I II III A B C(80 ) 1 n (1 + x) n (1) n C 1 + n C
8 ( ) 8 5 4 I II III A B C( ),,, 5 I II A B ( ),, I II A B (8 ) 6 8 I II III A B C(8 ) n ( + x) n () n C + n C + + n C n = 7 n () 7 9 C : y = x x A(, 6) () A C () C P AP Q () () () 4 A(,, ) B(,, ) C(,,
More information日本消化器外科学会雑誌第25巻第12号
Key words: poorly differentiated gastric carcinoma, medullary gowth pattern, Grimelius staining, immunohistochemistry, c-erbb-2 Fig. 2 Acinar type tumors. Several neoplastic cells aggregated and formed
More informationMicrosoft Word - 14外陰2012_20131008
外 陰 (C51) 外 陰 に 原 発 する 悪 性 腫 瘍 は ICD-O 分 類 の 場 合 局 在 コード C51. に 分 類 される UICC 第 7 版 においては 外 陰 の 原 発 癌 の 場 合 外 陰 の 項 で 病 期 分 類 を 行 うこととなった 原 発 癌 以 外 の 悪 性 腫 瘍 が 原 発 した 場 合 リンパ 腫 は Ann Arbor 分 類 に 従 った 病
More information佐賀県 悪性新生物届出票記載要領
埼 玉 県 地 域 がん 登 録 届 出 票 記 入 要 領 参 考 資 料 2012/4 1. 部 位 の 記 載 例 1 1-1. 左 右 の 記 載 6 2. 病 理 診 断 名 の 記 載 例 7 3. 病 巣 の 拡 がり の 記 載 例 17 1. 部 位 の 記 載 例 部 位 名 については 下 記 の 記 載 例 を 参 考 にご 記 入 ください( 部 位 例 については 疾 病
More information6. 清水愛, 上野孝, 鶴田恭子, 大森裕也, 新井桃子, 久保田智樹, 川名誠司. 手指の壊疽を呈した Steal 症候群の 1 例. 皮膚臨床 58: 市山進, 上野孝, 高山良子, 稲葉基之, 秋山美知子, 藤本和久, 安齋眞一, 船坂陽子, 佐伯秀久, S
最近 10 年間の業績 2017 年 1. Kanzaki A, Ansai SI, Ueno T, Kawana S, Shimizu A, Naito Z, Saeki H. A case of metastatic basal cell carcinoma treated with cisplatin and adriamycin. J Nippon Med Sch 84: 286-290.
More information11夏特集号初校.indd
1 2 3 5 50 40 7 6 3 ABC 3 5 A 5% B C 100 3 1 2 3 A 5% 5% 5% B 10% 5% 0% C 20% 10% 15% A 15.8% 15.0% 0.8% B 15.5% 15.0% 0.5% C 12.2% 15.0% 2.8% 2,000 1,500 1,000 500 0 10% 5% 3% 1% 01 5 10 15 20 25 30
More informationA05002 A05005 A05017 200. CEA B. CA-19 C. CA-125 D. HCG E. α-fetoprotein Papillary serous carcinoma α fetoprotein. 22-8 05019 A05039 KK A05039 KK A 17-year-olf high school senior presents to his local
More informationQ&A Q&A Q&A Q&A 53
Cells 2015 4 10 11 12 14 23 Q&A 26 27 31 Q&A 34 35 Q&A 43 1 44 1 52 Q&A 53 A4 P28 P29 P30 P30 P30 Cells A12 1 A 2014 Cells A4 2 12 Cells 103 1. 103 2. 1 3. 1 103 1141 70S21.1.1 //1 8 1 8P39 103 1141
More information